Site Map
 
 

 

 
 

 

Sonablate

System Information

Operations

Results

Users

Clinical Publications


THS International

Home

Distribution Information

Contact Information

 

SONABLATE® 500
 

Clinical Publications

The following list is a short summary of some of the recent and indicative publications and presentations on the advanced Sonablate® 500 HIFU system.  For more information or a more complete listing please contact info@thsinternational.com .

 

Clinical Efficacy & Outcomes

T. Uchida, M. Nitta, S. Hongo, S. Shoji, Y. Nagata, Y. Usui, T. Terachi, Tokyo University Hachioji Hospital - Tokai University, Tokyo, Japan, "High Intensity Focused Ultrasound For The Treatment In 517 Patients With Localized Prostate Cancer", Presented at the 29th SIU-Congress, Paris, France September 2007.

 

M. Emberton, R. Illing, T. Leslie, J. Kennedy, J. Calleary, C. Ogden, Institute of Urology and Nephrology, University College London, London, England, “Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: a proposed standard for the conduct of therapy”, British Journal of Urology, July, 2006.

 

Long term Efficacy

8 Year Follow-Up: T. Uchida, M. Nitta, S. Hongo, S. Shoji, Y. Nagata, Y. Usui, T. Terachi, Tokyo University Hachioji Hospital - Tokai University, Tokyo, Japan, "High Intensity Focused Ultrasound For The Treatment In 517 Patients With Localized Prostate Cancer", Presented at the 29th SIU-Congress, Paris, France September 2007.

 

T. Uchida, H. Yamashita, H. Ohkusa and Y. Nagata, "Clinical Outcome of HIFU for the Treatment of Localized Prostate Cancer: 5-Year Experience", presented at the International Symposium on Therapeutic Ultrasound,  Boston, Massachusetts, September, 2004.

 

 

Quality of Life and Complication Rates

T. Uchida, e. Yamashita, Y. Okusa, T. Nagat, Tokai University Hachioji Hospital, Tokyo, Japan, “Quality of life in patients with high-intensity focused ultrasound (HIFU) for localized prostate cancer”, poster presentation at Japan Endourology & ESWL Conference, Okayama, Japan, November, 2004.

 

 

Salvage HIFU Applications

M.Emberton, E. Zacharakis, H. Ahmend, A. Ishaq, R. Scott, R. Illing, A. Freeman, C. Allen, University College London Hospitals, London, England, “The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy”, British Journal of Urology, March 2008.

 

M. Hayashi, T. Asano, T. Uchida, Tokai University Hachioji Hospital, Tokyo, Japan, “Experience of transrectal high-intensity focused ultrasound for treatment of patients with biochemical failure after radical prostatectomy”, poster presentation at Japan Endourology & ESWL Conference, Tokyo, Japan, November, 2007.

 

 

Explanation of the Technology and Advanced Features

M. Emberton, R. Illing, University College Hospitals London, London, England, “Sonablate® 500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer”, Expert Review Medical Devices 3(6), 717-729 (2006).

 

T. Gardner, M. Koch, Indiana University Medical Center, Indianapolis, Indiana, “Prostate cancer therapy with high-intensity focused ultrasound”, Clinical Genitourinary Cancer, Vol. 4, No. 3, 187-192, 2005.

 

 

Future Uses of Sonablate® 500 HIFU Technology

M. Marberger, H.C. Klinger, M. Susani, R. Seip, J. Mauermann, N. Sanghvi, University of Vienna Medical College, Vienna, Austria, “A novel approach to energy ablative therapy of small renal tumours: laparoscopic high-intensity focused ultrasound”, European Association of Urology Journal, November, 2007.

 

 

 

©2005-2011 THS International, Inc.